AKRO PHARMACEUTICAL COMPANY LIMITED

Active

Registry details

Reference data exactly as held at Companies House.

Copy registry details
Registered office
Abacus House, 68a North Street, Romford, Essex RM1 1DA
Accounts type
Total Exemption Full

Company activity

The 4 most recent documents filed at Companies House.

Pre-Score for UK companies is coming soon
  1. 15/07/2026

    Statement of capital following an allotment of shares on 2026-06-01

    View PDF (3 pages)
  2. 27/02/2026

    Total exemption full accounts made up to 2025-05-31

    View PDF (8 pages)
  3. 10/11/2025

    Confirmation statement made on 2025-09-28 with no updates

    View PDF (3 pages)
  4. 24/12/2024

    Total exemption full accounts made up to 2024-05-31

    View PDF (8 pages)

Accounts and confirmation statement

The two filings Companies House requires every year, and where each one stands against its deadline today.

Annual accounts

Total Exemption Full accounts

On schedule

28/02/2027Filing deadline

Next accounts made up to
31/05/2026
Last accounts made up to
31/05/2025

Confirmation statement

Confirms the registry record is up to date

On schedule

11/08/2027Filing deadline

Next statement date
28/07/2027
Last statement dated
28/07/2026

See the full filing history

Financial performance

The latest figures AKRO PHARMACEUTICAL COMPANY LIMITED filed. Okredo holds filed accounts data for 2021–2025; the year-by-year record is on the financials page.

Net Assets

£399.22K2025
8.59%vs 2024

2024: £367.62K

Total Assets

£2.01M2025
9.97%vs 2024

2024: £1.83M

Cash in Bank

£145.96K2025
-15.23%vs 2024

2024: £172.17K

Total Liabilities

£1.19M2025
16.09%vs 2024

2024: £1.02M

Employees

62025
+1vs 2024

2024: 5

Of the 4 measures with an earlier filing to compare against, 3 rose and 1 fell. Total assets moved furthest, up 9.97% on 2024. See the full financial analysis for AKRO PHARMACEUTICAL COMPANY LIMITED.

Employees

Headcount as reported to Companies House for 2021–2025.

52021
52022
52023
52024
62025
YearEmployeesChange
20256+1
202450
202350
202250
20215–

Reported employee count increased from 5 in 2021 to 6 in 2025. See how headcount moved alongside the reported financials.

Credit report

It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.

Officers

6

Directors, secretaries and other appointed officers, with the period each has served.

PersonRolePeriodConnected companies
Director28/09/1998–Present0
Director28/09/1998–Present1
Nominee Director28/09/1998–28/09/19986002
Nominee Secretary28/09/1998–28/09/19984765
Secretary28/09/1998–Present0
Director01/06/2012–Present12

Persons with significant control

9

Individuals or entities with significant control over the company, as declared to Companies House.

PersonPeriodConnected companies
01/03/2017–Present2
06/04/2016–01/03/20172
01/03/2017–Present1
06/04/2016–01/03/20171
01/03/2017–30/01/20242
06/04/2016–01/03/20170
06/04/2016–01/03/20171
01/03/2017–Present12
01/03/2017–30/01/20241

Filing history and recent activity

Every document on the Companies House record, newest first.

Filings on record
82
Since 28/09/1998
Last 12 months
3
+1 vs the year before
Most recent filing
15/07/2026
2 months ago

What changed in the last year

  • Share capitalLatest 15/07/2026
  • Accounts filedLatest 27/02/2026
  • Confirmation statementLatest 10/11/2025

Filing timeline

  1. 15/07/2026

    Statement of capital following an allotment of shares on 2026-06-01

    View PDF (3 pages)
  2. 27/02/2026

    Total exemption full accounts made up to 2025-05-31

    View PDF (8 pages)
  3. 10/11/2025

    Confirmation statement made on 2025-09-28 with no updates

    View PDF (3 pages)
  4. 24/12/2024

    Total exemption full accounts made up to 2024-05-31

    View PDF (8 pages)
  5. 09/10/2024

    Confirmation statement made on 2024-09-28 with no updates

    View PDF (3 pages)
  6. 15/04/2024

    Notification of Samuel Tetteh Adjei as a person with significant control on 2017-03-01

    View PDF (2 pages)
  7. 15/04/2024

    Notification of Felicia Gloria Adjei as a person with significant control on 2017-03-01

    View PDF (2 pages)
  8. 28/02/2024

    Total exemption full accounts made up to 2023-05-31

    View PDF (12 pages)
  9. 30/01/2024

    Cessation of Samuel Tetteh Adjei as a person with significant control on 2024-01-30

    View PDF (1 pages)
  10. 30/01/2024

    Change of details for Mr Karl Adjei as a person with significant control on 2024-01-30

    View PDF (2 pages)
  11. 30/01/2024

    Cessation of Felicia Gloria Adjei as a person with significant control on 2024-01-30

    View PDF (1 pages)
  12. 26/01/2024

    Notification of Felicia Gloria Adjei as a person with significant control on 2017-03-01

    View PDF (2 pages)

Showing 12 of 82 filings

See when the next accounts and confirmation statement are due

Similar companies

1,377 UK companies are similar to AKRO PHARMACEUTICAL COMPANY LIMITED, sharing the same company status (Active), the same industry sector and activity group (Wholesale of pharmaceutical goods) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.

1,377 UK companies share this business profileThe 5 above are the closest matches. See every UK company registered under Wholesale of pharmaceutical goods.Browse the listing

About AKRO PHARMACEUTICAL COMPANY LIMITED

A short description of the company, written from its Companies House record.

AKRO PHARMACEUTICAL COMPANY LIMITED is a private limited company registered in the United Kingdom, based in Abacus House, 68a North Street, Romford, Essex RM1 1DA. Companies House classifies its business as Wholesale of pharmaceutical goods. It has been on the register for 28 years.

The register currently records it as active. Its 2025 accounts report net assets of £399.22K and 6 employees.

AKRO PHARMACEUTICAL COMPANY LIMITED: frequently asked questions

Answered from this company's own registry record and filed figures.

Companies House records AKRO PHARMACEUTICAL COMPANY LIMITED under one registered business activity: Wholesale of pharmaceutical goods (46.46 - SIC 2007).

AKRO PHARMACEUTICAL COMPANY LIMITED is recorded as active on the Companies House register, and has been on it since 28/09/1998.

The most recent accounts Okredo holds cover 2025 and report net assets of £399.22K, total assets of £2.01M, cash in bank of £145.96K and total liabilities of £1.19M.

The most recent document on the record is dated 15/07/2026: Statement of capital following an allotment of shares on 2026-06-01, 2 months ago.

On the current registry record, accounts are due by 28/02/2027 and the next confirmation statement is due by 11/08/2027.

Companies House lists 6 officers (4 currently in post) and 9 people with significant control (3 current).